You just read:

FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients

News provided by

Janssen Research & Development, LLC

Oct 24, 2013, 04:00 ET